Jump to: navigation, search
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass477.592 g/mol

WikiDoc Resources for Hitachimycin


Most recent articles on Hitachimycin

Most cited articles on Hitachimycin

Review articles on Hitachimycin

Articles on Hitachimycin in N Eng J Med, Lancet, BMJ


Powerpoint slides on Hitachimycin

Images of Hitachimycin

Photos of Hitachimycin

Podcasts & MP3s on Hitachimycin

Videos on Hitachimycin

Evidence Based Medicine

Cochrane Collaboration on Hitachimycin

Bandolier on Hitachimycin

TRIP on Hitachimycin

Clinical Trials

Ongoing Trials on Hitachimycin at Clinical

Trial results on Hitachimycin

Clinical Trials on Hitachimycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hitachimycin

NICE Guidance on Hitachimycin


FDA on Hitachimycin

CDC on Hitachimycin


Books on Hitachimycin


Hitachimycin in the news

Be alerted to news on Hitachimycin

News trends on Hitachimycin


Blogs on Hitachimycin


Definitions of Hitachimycin

Patient Resources / Community

Patient resources on Hitachimycin

Discussion groups on Hitachimycin

Patient Handouts on Hitachimycin

Directions to Hospitals Treating Hitachimycin

Risk calculators and risk factors for Hitachimycin

Healthcare Provider Resources

Symptoms of Hitachimycin

Causes & Risk Factors for Hitachimycin

Diagnostic studies for Hitachimycin

Treatment of Hitachimycin

Continuing Medical Education (CME)

CME Programs on Hitachimycin


Hitachimycin en Espanol

Hitachimycin en Francais


Hitachimycin in the Marketplace

Patents on Hitachimycin

Experimental / Informatics

List of terms related to Hitachimycin

Hitachimycin, also known as stubomycin, is a cyclic polypeptide produced by Streptomyces that acts as an antibiotic. It exhibits cytotoxic activity against mammalian cells, Gram-positive bacteria, yeast, and fungi, as well as hemolytic activity; this is mediated by changes at the cell membrane and subsequent lysis.[1] Owing to its cytotoxic activity against mammalian cells and tumors, it was first proposed as a antitumor antibiotic.[2]

As of 2007, it has not been used in a clinical setting.


  1. Komiyama K, Edanami K, Tanoh A, Yamamoto H, Umezawa I (1983). "Studies on the biological activity of stubomycin". J. Antibiot. 36 (3): 301–11. PMID 6833150.
  2. Umezawa I, Takeshima H, Komiyama K, Koh Y, Yamamoto H, Kawaguchi M (1981). "A new antitumor antibiotic, stubomycin". J. Antibiot. 34 (3): 259–65. PMID 7275806.